Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
Addiction Medicine - Catalyst Pharmaceutical Partners Announces Top-Line Results of CPP-109 Phase II Trial for Cocaine Addiction
ImmunoCellular Therapeutics, Ltd. - Clinical Data from Trial of ImmunoCellular Therapeutics’ Cancer Vaccine ICT-107 to Be Presented at ASCO 2009 Annual Meeting
PolyMedix, Inc. - PolyMedix Receives Regulatory Clearance to Initiate Second Phase I Clinical Study of Novel Systemic Antibiotic Compound
Retinitis Pigmentosa - Results From Neurotech's NT-501 Phase 2 Retinitis Pigmentosa Studies Demonstrate Consistent Biological Effect on Photoreceptors
Vomiting - New Phase 3 Study of Tapentadol Immediate Release Tablets Published in Current Medical Research and Opinion Journal
Bone Research - Findings from University of Toronto advance knowledge in bone research
Breast Cancer - Data from J.A. Sparano et al provide new insights into breast cancer
Breast Cancer - New findings in breast cancer described by M.N. Dickler and co-researchers
Breast Cancer - Research on breast cancer reported by A. Gennari et al
Chronic Disease - Research on chronic disease discussed by scientists at University of South Australia
Epilepsy - New epilepsy study results reported from University of Reading
Gene Therapy - Research findings from B.E. Jaski et al update understanding of gene therapy
HIV/AIDS - New HIV/AIDS research from Y. Levy and co-researchers described
Life Sciences - Research on life sciences published by scientists at University of Paris
Ovarian Cancer - Findings from University of Texas advance knowledge in ovarian cancer
Prostate Cancer - New prostate cancer data have been reported by S.R.H. Davidson and co-authors
Small Cell Lung Cancer - Recent findings in small cell lung cancer described by A.M.F. Araujo and colleagues
Breast Cancer Therapy - Scientists at Duke University, Medical Oncology Department discuss research in breast cancer therapy
Endometriosis Clinical Trial - Investigators at Shanghai Jiao Tong University zero in on endometriosis clinical trial
Gastric Cancer Therapy - Data from National Tumour Institute provide new insights into gastric cancer therapy
Leukemia Therapy - Findings from University of Vermont, Division of Hematology-Oncology advance knowledge in leukemia therapy
Non-Small Cell Lung Cancer Therapy - New non-small cell lung cancer therapy study findings have been published by scientists at University of North Carolina, Lineberger Comprehensive Cancer Center
4SC AG - 4SC presents Phase I data on its histone deacetylase HDAC inhibitor 4SC-201 at ASCO
Affymax, Inc. - Affymax® Reports Phase 2 Clinical Trial Data Supporting Hemoglobin Increases with Once-Per-Month Hematide™ Regardless of Patient Baseline Renal Function
Bladder Cancer - BioCis Pharma Starts a Phase I Clinical Trial With a New Cancer Drug
Brain Cancer - Peregrine Pharmaceuticals Reports Progress in Cotara(R) Brain Cancer Clinical Program
Breast Cancer - New Preliminary Data from Two Studies Show Clinical Activity of Neratinib in Combination with Trastuzumab and in Combination with Paclitaxel in Advanced HER-2 Positive Breast Cancer
Burzynski Research Institute, Inc. - Metastatic Colon Cancer: In a Randomized Phase II Clinical Study, Antineoplaston Therapy Doubled the 5-Year Survival Rate Following Curative Resection of Hepatic Metastases
Cancer - Kinex Pharmaceuticals To Present at ASCO 2009 Annual Meeting
Cancer - TRACON Pharmaceuticals' Small Molecule TRC102 and Antibody TRC105 to be Presented at ASCO 2009
Clinipace - Clinipace to Manage Two Phase II Clinical Trials for Inspire Pharmaceuticals
Colon Cancer - Poniard Pharmaceuticals Announces Progression-Free Survival Data From Phase 2 Clinical Trial of Picoplatin in Metastatic Colorectal Cancer
Diabetes - InteKrin Therapeutics to Present at the 2009 American Diabetes Association Annual Meeting
DSP Clinical Research - Darlene Panzitta, President and Founder of DSP Clinical Research, Named Ernst & Young Entrepreneur of the Year 2009 Award Finalist
Elixir Pharmaceuticals, Inc. - Elixir Pharmaceuticals Signs Option Agreement with a Major Pharmaceutical Company; Completes $12M Equity Financing
Flu Vaccines - Intercell AG Announces First Subject Enrolled in a Phase II Trial for the Further Development of Its Investigational Vaccine Enhancement Patch to Improve Pandemic Influenza Prevention in Collaboration With U.S. Department of Health and Human Services LE
Gene Therapy - Celladon Corporation Announces Presentation of First-in-Human Gene Transfer to Treat Heart Failure at the 12th Annual Meeting of the American Society of Gene Therapy
Gene Therapy - Celladon Provides MYDICAR(R) Program Update of First-In-Human Trial for Advanced Heart Failure at American Society of Gene Therapy Annual Meeting
Gene Therapy - Ceregene Presents Additional Clinical Data from Phase 2 Trial of CERE-120 for Parkinson's Disease
Genzyme Corp. - Genzyme and Isis Announce that Mipomersen Phase 3 Study in Patients with Homozygous Familial Hypercholesterolemia Met Primary Endpoint
Heart Failure - Results and Additional Analyses From Efficacy and Safety Study of Corthera's Relaxin in Acute Heart Failure to be Presented at Heart Failure Congress 2009
Hepatocellular Cancer - Phase 3 Trial Initiated to Evaluate Combination Therapy of Nexavar(R) and Tarceva(R) in Patients with Liver Cancer
HUYA Bioscience International, Llc - Chipscreen and HUYA Bioscience to Present Clinical Data on Novel HDAC Inhibitor at the 2009 ASCO Annual Meeting
Leukemia - Medarex Announces Allowance of Investigational New Drug Application for Wholly-Owned Fully Human Anti-CXCR4 Antibody, MDX-1338
Lux Biosciences, Inc. - Lux Biosciences’ Luveniq™ LX211 Highlighted at International Conference on Ocular Inflammation
Memgen - Memgen’s ISF35 Clinical Trial Featured at ASCO Annual 2009 Meeting
Millennium: The Takeda Oncology Company - VELCADE® Bortezomib for Injection and Pipeline Data to Be Highlighted at American Society of Clinical Oncology Annual Meeting
Neuroblastoma - New Therapy Enlists Immune System to Boost Cure Rate in a Childhood Cancer
Santarus, Inc. - Santarus to Present at UBS Global Specialty Pharmaceuticals Conference 2009
Seattle Genetics, Inc. - Seattle Genetics to Present SGN-35 and Lintuzumab Clinical Data at the European Hematology Association Congress
Stem Cell Research - Fate Therapeutics Announces First Patient Treated in Phase 1b Clinical Trial of FT1050 for Hematopoietic Stem Cell Support
Sunesis Pharmaceuticals, Inc. - Sunesis Announces New Data on Voreloxin for Acute Myeloid Leukemia and Ovarian Cancer Will Be Presented at ASCO
Type 2 Diabetes - Poxel SAS Set up to Find Innovative Solutions for Metabolic Diseases Management
Vertex Pharmaceuticals Incorporated - Vertex Pharmaceuticals Initiates Phase 3 Registration Program for VX-770, an Oral CFTR Potentiator Targeting the Defective Protein Responsible for Cystic Fibrosis
